Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Anupriya Singhal

Matched on ORCID iD 0000-0001-8816-0065; OpenAlex author ID A5024898449; NIH RePORTER profile ID 78318161. Sources: funder_awards.

Their work

Papers
7
Trials
0
Grants
3
Labs led
1
Collaborators
32
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers, 1 grant · 2026: 2 papers, 2 grants

Papers 7

  1. Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. Co-author DOI 10.1038/s41591-026-04299-5↗
  2. Pancreatic Cancer: Translating Tumor Biology into Actionability. Co-author DOI 10.1158/2159-8290.cd-25-2014↗
  3. Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort. Co-author DOI 10.1093/jnci/djae269↗
  4. Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/jnci/djaf139↗
  5. Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease. Co-author DOI 10.1093/jnci/djae095↗
  6. A Classical Epithelial State Drives Acute Resistance to KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0740↗
  7. Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. Co-author DOI 10.1158/0008-5472.can-22-1742↗

Grants 3

  1. Defining epigenetic drivers of cell-state plasticity in pancreatic cancer AWARD pancan:2026-anupriya-singhal-md-phd-defining-epigenetic-drivers-of-cell-stat
  2. Defining epigenetic drivers of cell-state plasticity in pancreatic cancer K08CA308851↗
  3. Interrogating vulnerabilities of a KRAS inhibitor-resistant cell state in pancreatic cancer AWARD lustgarten:2025-anupriya-singhal-md-phd-interrogating-vulnerabilities-of-a-kras-

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wungki Park · 4 shared papers, 2024–2026 · strength 0.83
  2. Eileen Mary O'Reilly · 4 shared papers, 2024–2026 · strength 0.83
  3. Fiyinfolu O. Balogun · 4 shared papers, 2024–2026 · strength 0.83
  4. Marinela Capanu · 3 shared papers, 2024–2025 · strength 0.53
  5. Anna M. Varghese · 3 shared papers, 2024–2025 · strength 0.53
  6. Fergus Keane · 3 shared papers, 2024–2025 · strength 0.53
  7. Darren Cowzer · 3 shared papers, 2024–2025 · strength 0.53
  8. Kenneth H. Yu · 3 shared papers, 2024–2025 · strength 0.53
  9. Kevin C. Soares · 2 shared papers, 2025–2026 · strength 0.47
  10. Christine A. Iacobuzio–Donahue · 2 shared papers, 2022–2026 · strength 0.43
  11. Fionnuala Crowley · 2 shared papers, 2025 · strength 0.36
  12. Alice Chia-Chi Wei · 2 shared papers, 2025 · strength 0.36
  13. Rona D. Yaeger · 2 shared papers, 2024 · strength 0.34
  14. Marsha Reyngold · 1 shared paper, 2026 · strength 0.30
  15. Mara H. Sherman · 1 shared paper, 2026 · strength 0.30
  16. Olivera Grbovic-Huezo · 2 shared papers, 2022–2024 · strength 0.29
  17. Tuomas Tammela · 2 shared papers, 2022–2024 · strength 0.29
  18. Lily V. Saadat · 1 shared paper, 2025 · strength 0.19
  19. Vinod P. Balachandran · 1 shared paper, 2025 · strength 0.17
  20. Ghassan K. Abou‐Alfa · 1 shared paper, 2025 · strength 0.17
  21. T. Peter Kingham · 1 shared paper, 2025 · strength 0.17
  22. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.17
  23. Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.17
  24. David Paul Kelsen · 1 shared paper, 2025 · strength 0.17
  25. William R. Jarnagin · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.